Please assess the completion status of the following clinical trial:

Trial Title: Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed as having endometriosis by laparotomy or laparoscopy, or by identification of chocolate cyst of endometriosis, or patients with the clinical diagnosis of endometriosis, who fulfill the condition of pelvic tenderness or induration of Cul-de-sac or uterine immobility~* Patient with pelvic pain judged by the highest Visual Analogue Scale (VAS) value of 40 mm or higher which is determined during 2 menstrual cycles before randomization (baseline observation phase)~* Patients having the normal menstrual cycle (25 to 38 days) in the latest two menses before randomization (baseline observation phase)~* Patients who do not wish to become pregnant during the course of the study~Exclusion Criteria:~* Patients who have organic diseases of which surgical treatment is prioritized by investigator~* Patients in whom any hormonal therapies, including combined oral contraceptives (COCs) and progestins, have failed for treatment of symptomatic endometriosis (moderate, severe pain)~* Patients for whom YAZ Combination Tablet is contraindicated (according to Japanese Labeling)~* Patients for whom dienogest is contraindicated (according to Japanese labeling of Dinagest Tab 1mg)

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): None
- Arm 2 (Type: EXPERIMENTAL): None
- Arm 3 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).